Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Roche”

A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric CancerCompleted
NCT01461057Phase 2Updated Aug 9, 2018
Sponsor: Hoffmann-La Roche
Gastric Cancer
Belgium, Czechia, France, Germany, Italy +3 more
The VMVN Study: Virological Monitoring in Viet NamCompleted
NCT01317498NAUpdated Aug 3, 2018
Sponsor: Beth Israel Deaconess Medical Center
HIV Infection · AIDS
Vietnam
A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's SyndromeCompleted
NCT02701985Phase 2Updated Aug 1, 2018
Sponsor: Hoffmann-La Roche
Sjogren's Syndrome
United States, France, Germany, Poland, Portugal +1 more
Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial InfarctionCompleted
NCT01374321Phase 2Updated Aug 1, 2018
Sponsor: Hoffmann-La Roche
Acute Myocardial Infarctus
Denmark, France, Norway, Sweden
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.Withdrawn
NCT00577109Phase 2Updated Jul 31, 2018
Sponsor: Hoffmann-La Roche
Colorectal Cancer
Brazil
An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal CancerCompleted
NCT01712347N/AUpdated Jul 31, 2018
Sponsor: Hoffmann-La Roche
Colorectal Cancer
Taiwan
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer: Continued Avastin Plus Chemotherapy After First Progression in Clinical PracticeCompleted
NCT02287597N/AUpdated Jul 30, 2018
Sponsor: Hoffmann-La Roche
Colorectal Cancer
Croatia
A Study of RO6870868 in Healthy VolunteersCompleted
NCT01911611Phase 1Updated Jul 26, 2018
Sponsor: Hoffmann-La Roche
Healthy Volunteer
Netherlands
A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment.Completed
NCT02679001N/AUpdated Jul 26, 2018
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Sweden
An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic CancerCompleted
NCT01782690N/AUpdated Jul 23, 2018
Sponsor: Hoffmann-La Roche
Pancreatic Cancer
Germany
Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular AtrophyCompleted
NCT02391831NAUpdated Jul 19, 2018
Sponsor: Institut de Myologie, France
Type 2 Spinal Muscular Atrophy · Type 3 Spinal Muscular Atrophy
Belgium, France, Germany
A Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) for the Treatment of Chronic Renal Anemia in Participants With Diabetic NephropathyCompleted
NCT01191983Phase 4Updated Jul 18, 2018
Sponsor: Hoffmann-La Roche
Anemia
India
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.Completed
NCT00545532Phase 3Updated Jul 12, 2018
Sponsor: Hoffmann-La Roche
Influenza, Human
United States, Argentina, Belgium, Brazil, Bulgaria +21 more
A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic LeukemiaCompleted
NCT01609023N/AUpdated Jun 26, 2018
Sponsor: Hoffmann-La Roche
Lymphocytic Leukemia, Chronic
Greece
A Study of Subcutaneous C.E.R.A. for the Maintenance of Hemoglobin Levels in Participants With Chronic Renal Anemia Not on Dialysis.Completed
NCT00642304Phase 3Updated Jun 26, 2018
Sponsor: Hoffmann-La Roche
Anemia
Netherlands
An Observational Study of Herceptin (Trastuzumab) in Patients With HER2-positive Advanced Gastric CancerCompleted
NCT01220934N/AUpdated Jun 20, 2018
Sponsor: Hoffmann-La Roche
Gastric Cancer
Germany
An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS)Completed
NCT01990248N/AUpdated Jun 19, 2018
Sponsor: Hoffmann-La Roche
Malignant Melanoma
Austria, Belgium, Czechia, Germany, Ireland +5 more
Mycophenolate for Pulmonary SarcoidosisTerminated
NCT00262132Phase 3Updated Jun 18, 2018
Sponsor: Medical University of South Carolina
Pulmonary Sarcoidosis
United States
Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF)Completed
NCT02598193Phase 4Updated Jun 13, 2018
Sponsor: Hoffmann-La Roche
Idiopathic Pulmonary Fibrosis
United States, Canada, Denmark, France, Germany +3 more
A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC)Completed
NCT02738970Phase 1Updated Jun 12, 2018
Sponsor: Hoffmann-La Roche
Early Breast Cancer
New Zealand
A Study of Treatment With RO6864018 in Virologically Suppressed Participants With Chronic Hepatitis B Virus (HBV) InfectionCompleted
NCT02391805Phase 2Updated Jun 6, 2018
Sponsor: Hoffmann-La Roche
Hepatitis B, Chronic
Hong Kong, Malaysia, New Zealand, Singapore, South Korea +1 more
A Study of Emactuzumab and RO7009789 Administered in Combination in Participants With Advanced Solid TumorsCompleted
NCT02760797Phase 1Updated May 22, 2018
Sponsor: Hoffmann-La Roche
Neoplasms
United States, Belgium, France
Accu-Chek® CONNECT at School (CATS) Pediatric StudyCompleted
NCT02609633NAUpdated May 18, 2018
Sponsor: Hoffmann-La Roche
Diabetes Mellitus, Type 1
United States
A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia.Completed
NCT02098967Phase 1Updated May 17, 2018
Sponsor: Hoffmann-La Roche
Neoplasms, Myelogenous Leukemia, Acute
United States, Canada
Screening Of Adult urBan pOpulation To diAgnose Heart FailureUnknown
NCT03526601N/AUpdated May 16, 2018
Sponsor: General Hospital Murska Sobota
Heart Failure
Slovenia

Previous page Next page